Name: Latest research reports of Max Healthcare Institute Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Max Healthcare Institute Ltd.
Rating: 4
Author: Geojit BNP Paribas

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	08 Sep 2025	Max Healthcare	Consensus Share Price Target	1149.60	1251.70	-	8.88	buy	pdf Detailed Estimates
	10 Apr 2025	Max Healthcare	Geojit BNP Paribas	1149.60	1240.00	1123.15 (2.35%)	Target met	Accumulate	pdf post cache	Broker Report MAX HEALTHCARE INSTITUTE LIMITED Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2025	Max Healthcare	Edelweiss Target	1149.60	1320.00	1174.30 (-2.10%)	14.82	Buy	pdf post cache	Broker Report Max Healthcare \| Q3FY25 Result Update Edelweiss Bed expansion to bolster growth pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Max Healthcare	Axis Direct	1149.60	1315.00	1108.25 (3.73%)	14.39	Buy	pdf post cache	Broker Report Result Update:Max Healthcare Axis Direct We maintain a BUY rating on MAXHEALTH with a target price of Rs 1,315/share, representing an upside potential of 26% from the CMP. pdf Copy Link Share on Share on Share on Share on Alert
	11 Dec 2024	Max Healthcare	Axis Direct	1149.60	1315.00	1132.20 (1.54%)	14.39	Buy	pdf post cache	Broker Report Initiating Coverage:Max Healthcare Axis Direct We Initiate coverage on Max Healthcare Ltd. with a BUY rating and a target price of Rs 1,315/share, offering a 18% upside from the CMP. pdf Copy Link Share on Share on Share on Share on Alert
	25 Nov 2024	Max Healthcare	FundsIndia	1149.60	1185.00	971.75 (18.30%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE INS LTD FundsIndia pdf Copy Link Share on Share on Share on Share on Alert
	07 Nov 2024	Max Healthcare	Motilal Oswal	1149.60	1240.00	1078.75 (6.57%)	Target met	Buy	pdf post cache	Broker Report Higher patient volumes and realization drive EBITDA Motilal Oswal Max Healthcare (MAXH) delivered slightly better-than-expected operational performance in 2QFY25. The annualized EBITDA per bed improved to INR7.8m from INR7.0m QoQ at its existing centers. pdf Copy Link Share on Share on Share on Share on Alert
	20 Sep 2024	Max Healthcare	Motilal Oswal Target	1149.60	1240.00	1067.95 (7.65%)	Target met	Buy	pdf post cache	Broker Report On an expansion spree Motilal Oswal Max Healthcare (MAXHEALT) has aggressively increased its bed capacity through both organic and inorganic routes over the past three years. pdf Copy Link Share on Share on Share on Share on Alert
	20 Sep 2024	Max Healthcare	IDBI Capital	1149.60	1050.00	1067.95 (7.65%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE LTD UPDATE IDBI Capital pdf Copy Link Share on Share on Share on Share on Alert
	27 Jun 2024	Max Healthcare	IDBI Capital	1149.60	1050.00	920.75 (24.85%)	Target met	Buy	pdf post cache	Broker Report TECHNICAL PICK: MAX HEALTH CARE IDBI Capital pdf Copy Link Share on Share on Share on Share on Alert
	23 May 2024	Max Healthcare	Motilal Oswal Target	1149.60	930.00	803.05 (43.15%)	Target met	Buy	pdf post cache	Broker Report Ends FY24 on a healthy note Motilal Oswal Max Healthcare (MAX) delivered in-line performance for 4QFY24. The quarterly EBITDA continues to inch up since the listing (Aug’20), reaching INR4.9b for 4QFY24. Max has demonstrated superior execution across its hospitals, Max Lab, and Max@home segments, supported by a growing number of patients and improved realizations. pdf Copy Link Share on Share on Share on Share on Alert
	07 Nov 2023	Max Healthcare	Motilal Oswal Target	1149.60	700.00	597.45 (92.42%)	Target met	Buy	pdf post cache	Broker Report EBITDA on path to achieve newer highs Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	30 Aug 2023	Max Healthcare	Motilal Oswal Target	1149.60	660.00	575.35 (99.81%)	Target met	Buy	pdf post cache	Broker Report Impressive track record, robust outlook to sustain re-rating Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	10 Aug 2023	Max Healthcare	Edelweiss Target	1149.60	680.00	536.75 (114.18%)	Target met	Buy	pdf post cache	Broker Report Max Healthcare Institute \| Q1FY24 Result Update Edelweiss Healthy run continues pdf Copy Link Share on Share on Share on Share on Alert
	17 May 2023	Max Healthcare	Prabhudas Lilladhar Target	1149.60	565.00	522.60 (119.98%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE INST Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	17 May 2023	Max Healthcare	Motilal Oswal Target	1149.60	600.00	522.60 (119.98%)	Target met	Buy	pdf post cache	Broker Report Robust FY23; good progress in all operational aspects Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	09 May 2023	Max Healthcare	SBI Securities	1149.60	553.00	481.30 (138.85%)	Target met	Buy	pdf post cache	Broker Report Pick of the week Max Healthcare Institute Ltd. 09-05-2023 SBI Securities pdf Copy Link Share on Share on Share on Share on Alert
	07 Apr 2023	Max Healthcare	Motilal Oswal	1149.60	530.00	430.35 (167.13%)	Target met	Buy	pdf post cache	Broker Report Growth levers in place; Initiate coverage with a BUY rating Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	05 Feb 2023	Max Healthcare	Prabhudas Lilladhar	1149.60	500.00	435.50 (163.97%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE INST Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	03 Nov 2022	Max Healthcare	Prabhudas Lilladhar Target	1149.60	500.00	462.85 (148.37%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE INST Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Max Healthcare	Prabhudas Lilladhar	1149.60	427.00	396.85 (189.68%)	Target met	Buy	pdf post cache	Broker Report MAX HEALTHCARE INST Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

31.61% Gain from 52W Low

Max Healthcare Institute Ltd. share price target

Max Healthcare Institute Ltd. has an average share price target of 1268.57. The consensus estimate represents an upside of 10.35% from the last price of 1149.60. View 12 reports from 7 analysts offering long-term price targets for Max Healthcare Institute Ltd..

MAX HEALTHCARE INSTITUTE LIMITED

Max Healthcare | Q3FY25 Result Update

Result Update:Max Healthcare

Initiating Coverage:Max Healthcare

MAX HEALTHCARE INS LTD

Higher patient volumes and realization drive EBITDA

On an expansion spree

MAX HEALTHCARE LTD UPDATE

TECHNICAL PICK: MAX HEALTH CARE

Ends FY24 on a healthy note

EBITDA on path to achieve newer highs

Impressive track record, robust outlook to sustain re-rating

Max Healthcare Institute | Q1FY24 Result Update

MAX HEALTHCARE INST

Robust FY23; good progress in all operational aspects

Pick of the week Max Healthcare Institute Ltd. 09-05-2023

Growth levers in place; Initiate coverage with a BUY rating

MAX HEALTHCARE INST

MAX HEALTHCARE INST

MAX HEALTHCARE INST

Advisor Screeners